MRTFA and neoplasm: The results of the CCK-8 assay, EdU assay and clone formation showed that treatment with MSCs Exo significantly reduced the proliferative capacity of tumor cells (Figure 6B-D) Moreover, it significantly reduced the expression of MKL-1 (Figure 6E-F).